Research Analysts Offer Predictions for BIO Q2 Earnings
Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) – Investment analysts at Zacks Research lowered their Q2 2025 earnings per share (EPS) estimates for Bio-Rad Laboratories in a note issued to investors on Thursday, May 22nd. Zacks Research analyst R. Department now expects that the medical research company will post earnings of $2.14 per share for […]
